UNSPSC 51451613: Oxfendazole sulfone

This classification denotes an antihelminthic agent with the molecular formula C15H13N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQM8UA6SPQ, chemically known as carbamic acid, n-(6-(phenylsulfonyl)-1h-benzimidazol-2-yl)-, methyl ester, but more generally known as oxfendazole sulfone, which bears US NIH Compound Identifier 162136. European Medicines Agency schedules oxfendazole sulfone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09519MIG.

Most nations, for tariff purposes, schedule oxfendazole sulfone under HS 29339990. SMILES: COC(=O)NC1[NH]C2CCC(CC2N1)S(=O)(=O)C3CCCCC3.

UNSPSC 51451613 Oxfendazole sulfone, a Commodity code, shows a mismatch between its nominal scope and recent state and local procurement activity. The code nominally covers a specific veterinary anthelmintic compound, yet the recent opportunities posted under this code address pharmaceuticals, medical supplies, and naloxone procurement—categories unrelated to oxfendazole sulfone. The recent solicitations reflect purchasing of naloxone and safe drug deactivation systems, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing agreements. This disconnect suggests that either the code assignment in the source material is erroneous or the code is being used as a catch-all placeholder for pharmaceutical procurement beyond its intended commodity scope.

Activity comes from a mix of issuing bodies including county health departments (Seminole County, Florida), municipal fire departments and purchasing offices (City of Tampa), and state health agencies coordinating multistate cooperative purchasing (Texas Health and Human Services Commission, Minnesota Department of Administration). The geographic spread includes Florida, Texas, Minnesota, and Oregon through the MMCAP cooperative vehicle. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's IFB for medical and first aid supplies to the Fire Department Rescue Division with an estimated contract value of $700,000.00 (due March 13, 2026), and the Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026) using authorized wholesalers AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC. Given the code's apparent misapplication to recent procurements, verifying the correct UNSPSC classification before pursuing activity under this code is advisable.